Alan L. Crane, Director at MOMENTA PHARMACEUTICALS INC (MNTA), sold 49,700 shares at $17.58 ($868K) on 2007-01-10, disclosed to the SEC on 2007-01-12.
Scheduled sale ($868k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.20 | 2,200 | $38K | 4.4% |
| 2 | $17.21 | 100 | $2K | 0.2% |
| 3 | $17.25 | 100 | $2K | 0.2% |
| 4 | $17.26 | 100 | $2K | 0.2% |
| 5 | $17.30 | 5,000 | $87K | 10.0% |
| 6 | $17.38 | 67 |
| $1K |
| 0.1% |
| 7 | $17.40 | 6,499 | $113K | 13.0% |
| 8 | $17.41 | 600 | $10K | 1.2% |
| 9 | $17.42 | 301 | $5K | 0.6% |
| 10 | $17.43 | 2,100 | $37K | 4.2% |
| 11 | $17.45 | 3,000 | $52K | 6.0% |
| 12 | $17.46 | 1,540 | $27K | 3.1% |
| 13 | $17.50 | 20,700 | $362K | 41.8% |
| 14 | $17.52 | 200 | $4K | 0.4% |
| 15 | $17.54 | 1,000 | $18K | 2.0% |
| 16 | $17.55 | 1,300 | $23K | 2.6% |
| 17 | $17.56 | 100 | $2K | 0.2% |
| 18 | $17.57 | 200 | $4K | 0.4% |
| 19 | $17.58 | 88 | $2K | 0.2% |
| 20 | $17.61 | 2,995 | $53K | 6.1% |
| 21 | $17.62 | 1,510 | $27K | 3.1% |
| Total | $17.46 avg | 49,700 | $868K | 100% |
| Filing → |
| CERU | BUY | 2014-04-15 | $10.3M | — | Filing → |
| MNTA | SELL | 2006-12-20 | $1.0M | — | Filing → |
| MNTA | SELL | 2006-12-12 | $880K | — | Filing → |